Ascend Gene & Cell Therapies’ $130 Million Series A Fundraise

Covington advised lead investors Abingworth and other syndicate members on the round.Ascend closed its $130 million Series A fundraise. Ascend will use the proceeds to launch as…

Standard 1 Year Membership Required

You must be a Standard 1 Year member to access this content.

Join Now

Already a member? Log in here
Laura Testa

Author: Laura Testa

Standard 1 Year Membership Required

You must be a Standard 1 Year member to access this content.

Join Now

Already a member? Log in here